Evaluation of Vamorolone CYP3A4 Induction on Midazolam (a Sensitive CYP 3A4 Substrate) Pharmacokinetics

Clinical trial NCT06689527 · COMPLETED

Trial details

NCT number: NCT06689527
Sponsor: Santhera Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug Interaction

Start date: 2024-08-13
Primary completion: 2024-09-24
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.